These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7498321)

  • 21. Effects of the selective 5-HT2A receptor antagonist MDL 100,907 on MDMA-induced locomotor stimulation in rats.
    Kehne JH; Ketteler HJ; McCloskey TC; Sullivan CK; Dudley MW; Schmidt CJ
    Neuropsychopharmacology; 1996 Aug; 15(2):116-24. PubMed ID: 8840347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the discriminative stimulus properties of the atypical antipsychotic drug clozapine in DBA/2 and C57BL/6 inbred mice.
    Porter JH; Walentiny DM; Philibin SD; Vunck SA; Crabbe JC
    Behav Pharmacol; 2008 Sep; 19(5-6):530-42. PubMed ID: 18690107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine and prazosin slow the rhythm of head movements during focused stereotypy induced by d-amphetamine in rats.
    Fowler SC; Pinkston JW; Vorontsova E
    Psychopharmacology (Berl); 2007 Jun; 192(2):219-30. PubMed ID: 17279374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A; Janssen PF; Megens AA; Leysen JE
    Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Jan; 12(1):1-5. PubMed ID: 6102768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.
    Idris NF; Repeto P; Neill JC; Large CH
    Psychopharmacology (Berl); 2005 May; 179(2):336-48. PubMed ID: 15645224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
    Olijslagers JE; Perlstein B; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Eur J Pharmacol; 2005 Sep; 520(1-3):77-85. PubMed ID: 16154561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: II. Functional profile in comparison to clozapine and haloperidol.
    Millan MJ; Schreiber R; Dekeyne A; Rivet JM; Bervoets K; Mavridis M; Sebban C; Maurel-Remy S; Newman-Tancredi A; Spedding M; Muller O; Lavielle G; Brocco M
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1356-73. PubMed ID: 9732399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.
    Janssen PA; Niemegeers CJ; Awouters F; Schellekens KH; Megens AA; Meert TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):685-93. PubMed ID: 2450200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats.
    Jackson DM; Johansson C; Lindgren LM; Bengtsson A
    Pharmacol Biochem Behav; 1994 Jun; 48(2):465-71. PubMed ID: 8090816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
    Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
    Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lu 35-138 ((+)-(S)-3-{1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-3,6-dihydro-2H-pyridin-4-yl}-6-chloro-1H-indole), a dopamine D4 receptor antagonist and serotonin reuptake inhibitor: characterisation of its in vitro profile and pre-clinical antipsychotic potential.
    Hertel P; Didriksen M; Pouzet B; Brennum LT; Søby KK; Larsen AK; Christoffersen CT; Ramirez T; Marcus MM; Svensson TH; Di Matteo V; Esposito E; Bang-Andersen B; Arnt J
    Eur J Pharmacol; 2007 Nov; 573(1-3):148-60. PubMed ID: 17689529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. alpha2C-Adrenoceptor blockade by clozapine and other antipsychotic drugs.
    Kalkman HO; Loetscher E
    Eur J Pharmacol; 2003 Feb; 462(1-3):33-40. PubMed ID: 12591093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys.
    Casey DE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):134-40. PubMed ID: 8935808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.